Date: October 18, 2023
Time: 9:00 AM (PDT), 12:00 PM (EDT), 6:00 PM (CEST)
In this webinar, Jenny Meredith, Ph.D., HCLD(ABB), Clinical Microbiology Director at Prisma Health-Upstate joins forces with Sara Ezra, Molecular Supervisor at Pathology Consultants (subsidiary of PathGroup) to discuss HPV testing from both the physician and laboratory lenses.
Dr. Meredith will share background on cervical cancer and HPV testing guidelines. She will then explain how the introduction of an HPV test with extended genotyping, the BD Onclarity™ HPV Assay, has enabled her to offer patients more personalized management.
Sara Ezra will review the instrumentation and workflow that has enabled this change from the lab side, including their validation process with the BD COR™ System as an early adopter, and her advice for launching a new assay.
Through prevalence data and case studies, they will illustrate how these changes have been able to impact patient care.
Learning Objectives
- Illustrate the value of an HPV test with extended genotyping beyond HPV types 16, 18 and 45, which individually identifies and reports more high-risk HPV types, including HPV 31
- Explain the impact of integrated lab automation on improving workflows for HPV testing, and the process for validation
- Demonstrate the impact that offering more precise and personalized HPV testing results has on patient management
Webinars will be available for unlimitted on-demand viewing after live event.